ALPINE IMMUNE SCIENCES, INC. Debt Securities, Available-for-sale, Current
ALPINE IMMUNE SCIENCES, INC. had Debt Securities, Available-for-sale, Current of $272.65 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2024-05-09
- 2024-03-31: Debt Securities, Available-for-sale, Current $272.65M.
- 2023-12-31: Debt Securities, Available-for-sale, Current $283.49M.
- 2023-09-30: Debt Securities, Available-for-sale, Current $174.47M.
- 2023-06-30: Debt Securities, Available-for-sale, Current $169.72M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2024-03-31 | $272.65M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $283.49M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $174.47M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $169.72M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $180.46M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $224.26M 10-K · filed 2024-03-20 |
| 2022-09-30 | $122.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $143.50M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $136.98M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $94.40M 10-K · filed 2023-03-23 |
| 2021-09-30 | $104.53M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $72.25M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $84.19M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $70.62M 10-K · filed 2022-03-17 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.00M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $11.24M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $24.40M 10-K · filed 2021-03-18 |
| 2019-09-30 | $29.19M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $40.10M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $22.52M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $41.59M 10-K · filed 2020-03-30 |
| 2017-12-31 | $73.24M 10-K · filed 2019-03-18 |